Wed, Aug 27, 2014, 5:02 AM EDT - U.S. Markets open in 4 hrs 28 mins


% | $
Quotes you view appear here for quick access.

Google Inc. Message Board

ran.dog80 151 posts  |  Last Activity: Aug 18, 2014 10:41 AM Member since: Nov 11, 2008
  • After Oregon and Alaska, pot advocates are eyeing Arizona, Montana, Massachusetts, and Nevada for 2016 ballot initiatives in their efforts to legalize marijuana. And activists are hopeful New York, which recently passed #$%$ legislation, will eventually do the same for the recreational version.

    It's coming soon and Supreme Pharma should do well.

  • ran.dog80 by ran.dog80 Jul 21, 2014 11:47 AM Flag

    Then you obviously don't understand what's happened or why we are better than Tweed. Our first acquisition is currently producing over 16,000 grams a month for patients they already have and have been doing so for over a year. We have loyal patients where as Tweed ( who is also short on supply and has suffered numerous setbacks of recalled medicine and a seized shipment which all cost Tweed $$ and it's shareholders) has had to find patients fast as they only opened for business April 1st of this year.

    As for not being able to believe why they did this to us (Reverse Split) .... This was the right move. I expect to see some nice highs and evening out which will present some strategic flipping opportunities to acquire more of these shares in a much smaller O/S float until the stock rockets after MMPR. Then we will far surpass Tweed, who hasn't even been able to utilize the entirety of their first facility and keep it free from quality issues yet they just acquired a GreenHouse. This in my opinion is an obvious reaction to Supremes very real threat on Tweeds entire business.

    Get ready for MMPR rise .

  • ran.dog80 by ran.dog80 Jul 18, 2014 6:33 PM Flag

    17. Who are the Licensed Producers?

    Licensed Producers are companies that have been authorized by Health Canada to grow and sell #$%$ under the new program.

    Many are start-up businesses headed by entrepreneurs with diverse backgrounds. However, a few Licensed Producers were formed by existing #$%$ companies, such as Holland-based Bedrocan and former Health Canada supplier Prairie Plant Systems.

    18. How many Licensed Producers are there?

    As of April 1, there are 12 Licensed Producers listed on Health Canada’s website. 4 of them currently have product available for sale: Bedrocan, CanniMed, Mettrum and Peace Naturals Project.

    19. How do I register with a Licensed Producer?

    After obtaining a medical document, patients can register with a Licensed Producer of their choice. The registration process is different for each Licensed Producer, but typically involves submitting a registration form and validating the medical document.

    20. Can I sign up with more than one Licensed Producer?

    Yes, but it’s complicated. Patients are permitted to register with more than one Licensed Producer, but a separate medical document must be submitted for each, meaning that a doctor will have to issue multiple medical documents and split the daily amount of marijuana between them.

    21. How do I become a Licensed Producer?

    Becoming a Licensed Producer involves applying through Health Canada. It is an expensive and time-consuming process, since the rules for growing and selling #$%$ are strict and require a sizeable investment to meet.

    But Health Canada predicts the MMPR to generate roughly $1.3 billion in yearly sales by 2024. Likewise, the industry has already become very competitive. Since last summer, Health Canada has received over 600 applications from hopeful Licensed Producers.

  • The stakes are so high that an application has been made in Federal Court for an injunction to prevent the MMRP from taking effect. The case was heard on March 18, and Vancouver lawyer John Conroy expected the judge to render a decision by April 1.

    Health Canada justifies the MMRP changes by citing reports from police and other agencies that the MMAP was being abused. Complaints range from improperly installed grow-ops being fire and mould hazards, to growers over-producing for the black market, to inconvenience and possible danger for neighbours.

    Conroy doesn't think much of the evidence presented.

    "When you analyze what few statistics they have, most being anecdotal stories, there's nothing to support the toxic mould concern. On cross examination, they couldn't provide any statistics on the number of fires in medical grows. The public safety hazard, again, I think there were one or two 'grow rips' that involved medical grows."

    Previous court cases like R vs. Parker ( Ontario Court of Appeal, 2000 ) have established certain principles tied to medical cannabis. Because many patients are on disability, financial hardship is a definite concern, as is quality control, and ensuring a reliable supply to safeguard patient well-being.

    The MMAP had been working just fine, Conroy argues, and the government's heavy-handed action violates patients' rights under s. 7 of the Charter.

    "On April 1, all these folks are going to be placed in a position of having to choose between their liberty and health. They're either going to be faced with being charged and have their liberty and security of person impacted, or they're going to have to go without effective medicine which impacts their health.

    "That's the irreparable harm that we will argue is going to occur if the court doesn't [grant an injunction].

  • attain a "NEW" license. All is a waste of time if they cut off the licensing process and allow only those currently holding one to move forward. Can someone email H.C. and ask that question?

  • Having less shares outstanding trading at a proportionately higher price should also facilitate the raising of the additional funds needed to complete construction at our Southern Ontario project so we can meet the conditions of our pre-build licence. That project is moving ahead on schedule and on budget."

    CEO David S. is saying that he expects the stock to trade higher than currents levels and therefore create income to complete construction. The part I don't understand is "pre- build". The facility is already there so that term is confusing. Again CEO needs to draw a clear picture fast for investors as to the Canadian Government allowing more licensees in the MMPR space. Country is fighting it for cost reasons stating their need to purchase through Health Canada Approved sources is much to high a price for grams of WEED!

  • would be occurring. It's not and I'm glad at the moment but still watching for more news from management on the matter. I guess we'll have to wait for the actual 5:1 R/S and see if it stays put or begins to fall/climb!

  • video of his confidence in attaining the MMPR license first would suggest a friendly merger would help both companies meet goals as "partners". Their actual prediction for a MMPR licence is August, one month away. When not if that happens expect 1000% s/p increase on announcement and more pressure on Abbatis as price falls to except the deal. At $0.09 and an MMPR license in weeks do you not want to own SPRWF, that's the question. 100X bigger production than Abbatis as well.

  • ran.dog80 ran.dog80 Jul 15, 2014 1:06 PM Flag

    Unclear on warrants needing to be gone before stock can climb. Can you explain and how do you justify the company's market cap / value doubling on simply eliminating warrants. Thanks much for your opinion.

  • ran.dog80 ran.dog80 Jul 13, 2014 11:42 AM Flag

    I'm still trying to understand how SPRWF is claiming they're Health Canada Licensed for MMPR when that's not really the case. They are currently fixing the items that were listed from the initial inspection by HC. That means they are not yet licensed. Only 12 licenses have been issued but it does seem likely more will be needed. They claimed to have been grandfathered from an old license but that's not meeting today's requirements so it's still a risk. Abbatis likewise needs to meet some discrepancies that were handed them but no one knows what they are or when the projected fixes will be done. So, at least SPRWH has given a hard date of Q3 2014 to satisfy their repairs and be licensed possibly. The whole thing is moving fast and if Abbatis is late to the game it could be a serious blow to them. I hope your predictions are good. GL.

  • Reply to


    by b_s_d_m_4pershare Jul 11, 2014 11:02 AM
    ran.dog80 ran.dog80 Jul 11, 2014 4:30 PM Flag

    Correction 12 licenses. Some claim to have the approval but when you read further they are still upgrading their facilities to meet the Health Canada standards. So are we but no one knows what's needed to get approval. Mike should address investors in a PR style letter and give updates as to when the re-submit may happen. It gives accountability to those wanting to enter and not risk further delays. If I were him I would speak soon on the matter.

  • ran.dog80 ran.dog80 Jul 11, 2014 12:00 PM Flag

    158M is not a low float. Supreme does not have a MMPR license and is currently trying to meet the requirements of Health Canada to get it. So in Abbatis with a really low float of just 58M. Good luck with SPRWF I hope both companies can get licensed, but I'm staying put here. Abbatis seems to be ahead of the pack for now ATTBF!

  • Reply to


    by b_s_d_m_4pershare Jul 11, 2014 11:02 AM
    ran.dog80 ran.dog80 Jul 11, 2014 11:33 AM Flag

    It could be today, or never, or somewhere in between. That is now up to Attabis management to draw exposure to their products and get the much needed MMPR license. Canada has only approved 18 licenses I think and there were like 875 applications. The Canadian exchange and the SEC warned investors about "FAKE" companies and their ticker symbols that were flooding the market with no chance of survival. They were applying for licenses but never had a chance and investors were told to do DD thoroughly before buying shares of such companies. Abbatis is not one of them and should eventually get licensed in Canada to grow/ distribute with a MMPR license.

  • a slew of positive PRs to entice additional investors to join in being on the new exchange and hopefully drawing more exposure to the company. Everything's in place now it's up to him to find customers/buyers of their brilliant product line and generate some much needed revenue! The sale of a few Bio cubes would get the ball rolling. The competition in the cannabis industry will heat up fast so being first to market is crucial!

    ATTBF must break through $0.76, then $0.86, and through $1.00 soon or things could begin to slide way back. A MMPR license in Canada would be huge but they have been challenged in getting approved. Mike has been served with those discrepancies that kept them from initial approval which investors know nothing about. Even a statement from him that Attabis has resubmitted for approval to MMPR license would show good management. When does Attibas expect to complete that task and join those already approved would draw investors in immediately!

    Mike, can you please address the situation at hand, Thank you.

  • Reply to

    unique service to medical cannibus industry

    by jackprdn Jul 10, 2014 1:30 PM
    ran.dog80 ran.dog80 Jul 10, 2014 3:51 PM Flag

    What connection is this to Abattis? None that I can see.

  • for MMPR? I saw Mike W. give his interview and explanation of receiving them but never highlighted the time line needed to address them. Is it days, months, or longer before they re- apply? Anyone have any information? They should have listed them on their website and then describe the actions to remedy.

  • ran.dog80 ran.dog80 Jul 9, 2014 10:40 AM Flag

    Starting to see their strategy as more of a liaison to grower/sellers of weed than a distributor themselves. They are focused on the technical and experimental properties and future medical uses. Not sure that has the Markets attention as much as the recreational part of this growing industry. That's where the money is today. Mike W. needs to get ATTBF partners with a company that is currently licensed and selling to the public in both Colorado and Washington St. Getting this company's share price above the $1 dollar mark soon will be crucial as many small weed plays will soon climb and leave ATTBF vulnerable to be forgotten.

  • ran.dog80 ran.dog80 Jul 7, 2014 10:13 PM Flag

    Just saw a video on Washington State legalizing weed and there is not enough supply and the cash payment only system is running into major road blocks. Seems ATTBF is ahead of the game with the payment pre- loaded card. This thing could take off as many other states want the legalized weed for tax purposes and ATTBF has a foot in the door already. Investors need to know what dependencies were handed Abattis at time of license application in Canada and what their doing to resolve them. This company seems miles ahead of the competition.

  • Vancouver, BC - February 20, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX:FLU), Health Canada Office of Controlled Substance has issued the deficiency list for Abattis' subsidiary, Northern Vine Canada Inc. application to obtain a Controlled Substance License for handling, analytics and extraction of Marihuana.


  • tomorrow could signal some much needed strength to $0.80. I like the fact that Mike W. withdrew from the 20M share sale @ $1.00 and focusing on shareholder value w/o further dilution. A lot of positives in Abbatis' future and good strategies in place for steady stream of income. This one should cross $1.00 very soon if projected estimates begin falling into place. The worlds eyes are on legalization in North America of weed for recreational and medical purposes. It's what keep my best friend alive as he was a paraplegic from 18 yrs. old to 60. The last 10 years of his life were so painful and we had to sneak weed to him for him to even rest at night. Now it's legal after his death, so sad for him so glad for those who will benefit from it very soon! Go Abbatis!

577.86-2.34(-0.40%)Aug 26 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.